Choosing a blood-glucose-lowering agent after metformin

Lancet. 2012 Jun 16;379(9833):2220-1. doi: 10.1016/S0140-6736(12)60780-6. Epub 2012 Jun 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Glargine
  • Insulin, Long-Acting / therapeutic use*
  • Male
  • Metformin / therapeutic use*
  • Pyrazines / therapeutic use*
  • Sitagliptin Phosphate
  • Triazoles / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Insulin, Long-Acting
  • Pyrazines
  • Triazoles
  • Insulin Glargine
  • Metformin
  • Sitagliptin Phosphate